Preview Mode Links will not work in preview mode

Feb 23, 2024

Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel, including the following topics:

  • Introduction: EMERALD-1 — Immune Checkpoint Inhibitor-Based Therapy for Localized HCC Eligible for Embolization (0:00)
  • Optimal Utilization of Immune Checkpoint Inhibitors as First-Line Therapy for Advanced HCC – Dr...


Feb 15, 2024

Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Andrea Cercek, Dr Cathy Eng and Dr John Strickler, moderated by Dr Christopher Lieu, including the following topics:

  • Introduction (0:00)
  • Optimizing Biomarker Assessment and Treatment for Patients with Metastatic Colorectal Cancer (mCRC) — Dr Eng (2:48)
  • Emerging...


Feb 7, 2024

Featuring perspectives from Dr David H Ilson, Dr Rutika Mehta, Dr Markus Moehler and Dr Manish A Shah, moderated by Dr Harry H Yoon, including the following topics:

  • Introduction (0:00)
  • Recent Developments in the Management of Localized or Locally Advanced Gastroesophageal Cancers — Dr Ilson (2:02)
  • Incorporation of...


Dec 14, 2023

Featuring perspectives from Dr Lipika Goyal and Dr Milind Javle, including the following topics:

  • Introduction (0:00)
  • First-Line Systemic Treatment (17:25)
  • Targeted Treatment (25:42)

CME information and select publications 


Dec 14, 2023

Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers | Faculty Presentation 2: Emerging Management Approaches for Patients with Advanced BTCs — Milind Javle, MD

CME information and select publications